Copyright
©The Author(s) 2017.
World J Gastroenterol. Jun 28, 2017; 23(24): 4354-4368
Published online Jun 28, 2017. doi: 10.3748/wjg.v23.i24.4354
Published online Jun 28, 2017. doi: 10.3748/wjg.v23.i24.4354
Table 1 Antibodies employed for this research
| Protein | Company | Catalog number | Dilution |
| TGF-β | Millipore | MAB1032 | 1:500 |
| α-SMA | Sigma Aldrich | A5691 | 1:500 |
| CTGF | Santa Cruz Biotechnology | SC-14939 | 1:500 |
| Col-1 | Sigma Aldrich | C-2456 | 1:500 |
| MMP-13 | Millipore | MAB13426 | 1:500 |
| NF-κB (p65) | Millipore | MAB3026 | 1:500 |
| IL-1 | Millipore | AB1832P | 1:500 |
| IL-10 | Invitrogen | ARC9102 | 1:500 |
| Smad3 | Abcam | Ab65847 | 1:500 |
| pSmad3L | Abcam | Ab63403 | 1:250 |
| Smad7 | Abcam | Ab90086 | 1:500 |
| JNK | Cell Signaling | 9252 | 1:500 |
| pJNK | Abcam | Ab131499 | 1:500 |
- Citation: Hernández-Aquino E, Zarco N, Casas-Grajales S, Ramos-Tovar E, Flores-Beltrán RE, Arauz J, Shibayama M, Favari L, Tsutsumi V, Segovia J, Muriel P. Naringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways. World J Gastroenterol 2017; 23(24): 4354-4368
- URL: https://www.wjgnet.com/1007-9327/full/v23/i24/4354.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i24.4354